Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
DEVRIAZ
Third Extension - Granted
Show more
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
Class 5 – Pharmaceuticals & supplements
Status timeline
- 3 Sep 2024Application filedNew Application Entered
- 25 Nov 2024Assigned to an examining attorneyAssigned To Examiner
- 27 Nov 2024Approved for publicationApproved For Pub - Principal Register
- 24 Dec 2024Published for oppositionPublished For Opposition
- 18 Feb 2025Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 11 Jul 2025Statement-of-use extension 1 grantedSou Extension 1 Granted
- 20 Jan 2026Statement-of-use extension 2 grantedSou Extension 2 Granted
- 28 Jul 2026Statement-of-use extension 3 grantedSou Extension 3 Granted
All 28 events
| 2026-07-29 | Notice Of Approval Of Extension Request E-Mailed |
| 2026-07-28 | Sou Teas Extension Received |
| 2026-07-28 | Sou Extension 3 Filed |
| 2026-07-28 | Sou Extension 3 Granted |
| 2026-01-30 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2026-01-30 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2026-01-30 | Teas Change Of Correspondence Received |
| 2026-01-30 | Teas Withdrawal Of Attorney Received-Firm Retains |
| 2026-01-21 | Notice Of Approval Of Extension Request E-Mailed |
| 2026-01-20 | Sou Teas Extension Received |
| 2026-01-20 | Sou Extension 2 Filed |
| 2026-01-20 | Sou Extension 2 Granted |
| 2026-01-15 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2026-01-15 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2026-01-15 | Teas Change Of Correspondence Received |
| 2026-01-15 | Teas Withdrawal Of Attorney Received-Firm Retains |
| 2025-07-12 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-07-11 | Sou Teas Extension Received |
| 2025-07-11 | Sou Extension 1 Filed |
| 2025-07-11 | Sou Extension 1 Granted |
| 2025-02-18 | Noa Mailed - Sou Required From Applicant |
| 2024-12-24 | Published For Opposition |
| 2024-12-24 | Official Gazette Publication Confirmation E-Mailed |
| 2024-12-18 | Notification Of Notice Of Publication E-Mailed |
| 2024-11-27 | Approved For Pub - Principal Register |
| 2024-11-25 | Assigned To Examiner |
| 2024-09-03 | New Application Entered |
| 2024-09-03 | New Application Office Supplied Data Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 29 Jul 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.